This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ELI-216

Elite Pharmaceuticals, Inc.

Drug Names(s): OxyNal, Oxycodone/naltrexone

Description: ELI-216 is an abuse-resistant oxycodone HCl. The drug is a combination of a narcotic agonist (oxycodone) in a sustained release formulation and an antagonist, naltrexone hydrochloride, formulated to deter abuse of the drug.


ELI-216 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug